Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Transplant. Jun 18, 2024; 14(2): 93567
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.93567
Table 1 Selected characteristics of heart transplant recipients according to multidrug-resistant organism presence
Heart transplant recipients
Total (n = 98)
MDRO presence (n = 32)
MDRO-free (n = 66)
P value
Demographics
Age (yr)50 (37-56)51 (41-56)45.5 (35.5-56)0.48
Sex (male)69 (70.4)25 (78.1)44 (66.7)0.24
Height (cm), SD172 (9)174 (8)172 (9)0.25
Body weight (kg), SD75 (15)81 (11)72 (16)0.002
ΒΜΙ (kg/m2), SD25.1 (3.8)26.9 (3)24.3 (3.9)0.001
Heart failure etiology
Non-ischemic cardiomyopathy75 (76.5)23 (71.9)52 (78.8)0.45
Ischemic cardiomyopathy22 (22.4)8 (25)14 (21.2)0.67
Comorbidities
Diabetes mellitus21 (21.4)8 (25)13 (19.7)0.54
CRF (eGFR ≤ 60 mL/min/m2)13 (13.3)8 (25)5 (7.6)0.017
Vasculopathy40 (40.8)17 (53.1)23 (34.8)0.08
COPD5 (5.1)2 (6.3)3 (4.5)0.72
Previous cardiac surgery18 (18.4)24 (75)38 (57.6)0.09
Smoking history55 (56.7)21 (65.6)34 (52.3)0.21
Status at transplantation
VAD54 (55.1)22 (68.8)32 (48.5)0.06
Admitted from home65 (66.3)20 (62.5)45 (68.2)0.10
Admitted from ward15 (15.3)5 (15.6)10 (15.2)0.95
Admitted from ICU18 (18.4)7 (21.9)11 (16.7)0.53
Operating room
General anesthesia (hours)7 (6-8)6.5 (6-8)7 (6-8)0.84
Extracorporeal circulation (min)168 (144-229)210 (146-271)161 (141-193)0.003
Aorta closure (min)115 (77-198)115 (85-130)115 (67-211)0.94
Transfusion (RBC units)4 (2-10)9.5 (4-13)4 (2-7)0.001
Post transplantation
Primary graft dysfunction13 (13.3)10 (31)3 (4.5)0.001
Surgical re-exploration20 (20.4)11 (34)9 (13.6)0.017
Ventilator days2 (1-5)5 (3-3.5)1.3 (1-3)0.001
NO for refractory hypoxemia25 (25.5)14 (43.8)11 (16.7)0.04
CRRT for renal failure15 (15.3)9 (28)6 (9)0.014
Post Tx mechanical circulatory support32 (32.7)15 (46.9)17 (25.8)0.037
ATG treatment (days)5 (4-7)6 (5-8)5 (4-6)0.08
Outcomes
ICU stay, days10 (7-17)15.5 (10-26)9 (7-12)0.001
Post transplantation total hospital stay, days30 (24-41)38 (25-62)28 (21-39)0.006
Early mortality (30 d)9 (1)6 (18.8)3 (4.5)0.02
Late mortality (1-year)14 (14.3)9 (28.1)5 (7.6)0.006
Died in ICU12 (12.2)8 (25)4 (6)0.003